Zilberman J M
Sección Hipertensión Arterial, Departamento de Prevención Cardiovascular, Instituto Cardiovascular de Buenos Aires (ICBA), Buenos Aires, Argentina; Sección Hipertensión arterial, Servicio de cardiología, Hospital General de Agudos Dr. Cosme Argerich, Buenos Aires, Argentina; Facultad de Farmacia y Bioquímica, Cátedra de Fisiología, Universidad de Buenos Aires, UBA, Buenos Aires, Argentina.
Hipertens Riesgo Vasc. 2018 Apr-Jun;35(2):77-83. doi: 10.1016/j.hipert.2017.11.001. Epub 2018 Feb 1.
Hypertension is the main cardiovascular risk factor affecting 25% of women. Hormone changes and hypertension after menopause may lead to higher target organ damage and cardiovascular disease such as increased arterial stiffness, coronary diseases, chronic heart failure and stroke. The physiopathological mechanisms involved in the development of hypertension and cardiovascular diseases in menopausal women are controversial. There are pharmacokinetic and pharmacodynamic differences in both sexes, the women have more coughing when using the converting-enzyme inhibitors, more cramps when using thiazide diuretics and more oedema in the inferior limbs when using calcium antagonists. The aim of this review is to analyse possible physiopathological mechanisms involved in hypertension after menopause and to gain a better understanding of the biological effects mediated by vascular ageing in women when the level of oestrogen protective effect decreases over the vascular system.
高血压是影响25%女性的主要心血管危险因素。绝经后的激素变化和高血压可能导致更高的靶器官损害和心血管疾病,如动脉僵硬度增加、冠心病、慢性心力衰竭和中风。绝经后女性高血压和心血管疾病发生发展过程中涉及的生理病理机制存在争议。两性在药代动力学和药效学方面存在差异,女性使用转换酶抑制剂时咳嗽更多,使用噻嗪类利尿剂时痉挛更多,使用钙拮抗剂时下肢水肿更多。本综述的目的是分析绝经后高血压可能涉及的生理病理机制,并在雌激素对血管系统的保护作用水平降低时,更好地理解血管衰老在女性中介导的生物学效应。